Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone/fentanyl era

Post written by Yoshihide Kanno, MD, from the Department of Gastroenterology, Sendai City Medical Center, Miyagi, Japan. The focus of our study was to evaluate the value of routine performance of EUS-guided celiac plexus neurolysis (EUS-CPN) at an early cancer-pain stage. EUS-CPN has been reported to be effective for patients with upper abdominal pain due …

Continue reading Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone/fentanyl era

EUS-guided radiofrequency ablation of unresectable pancreatic cancer

Tae Jun Song, MD, PhD, and Dong Wan Seo, MD, PhD, from the Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center in Seoul, South Korea presents this New Methods article, "Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer." We investigated the feasibility and safety of endoscopic ultrasound (EUS)-guided …

Continue reading EUS-guided radiofrequency ablation of unresectable pancreatic cancer

Editor’s Choice: Outcomes after endoscopic duodenal stent placement for malignant GOO

Associate Editor Fauze Maluf-Filho, MD, PhD, FASGE, highlights this Original Article from the September issue: "Survival and clinical outcome after endoscopic duodenal stent placement for malignant gastric outlet obstruction: comparison of pancreatic cancer and nonpancreatic cancer." The literature supports the concept that patients with malignant gastric outlet obstruction with a predicted survival longer than 3 …

Continue reading Editor’s Choice: Outcomes after endoscopic duodenal stent placement for malignant GOO

PGS technology to detect pancreatic cancer

Michael Wallace, MD, MPH from the Department of Gastroenterology and Hepatology at Mayo Clinic in Jacksonville, Florida, USA discusses his article "Polarization gating spectroscopy of normal-appearing duodenal mucosa to detect pancreatic cancer." In this study, we tested the hypothesis that pancreatic cancer is detectable from the normal appearing duodenum, using sophisticated spectroscopy methods. The concept …

Continue reading PGS technology to detect pancreatic cancer